中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 8
Aug.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(8): 1859-1864

Association between gallstones and metabolic syndrome in southern Xinjiang, China

DOI: 10.3969/j.issn.1001-5256.2022.08.026
  • 1.

    Department of Hepatobiliary Surgery, The First Affiliated Hospital of Shihezi University School of Medicine, Shihezi, Xinjiang 832008, China

  • 2.

    Shihezi University School of Medicine, Shihezi, Xinjiang 832008, China

Research funding:

Science and Technology Projects of XPCC (Xinjiang Production and Construction Group) (2018AB022)

More Information
  • Corresponding author: ZHANG Shie, Zhangshijiewk1@sina(ORCID: 0000-0001-8307-8978)
  • Received Date: 2021-12-14
  • Accepted Date: 2022-02-06
  • Published Date: 2022-08-20
    Abstract
  •   Objective  To investigate the association between gallstones (GS) and metabolic syndrome (MS) in southern Xinjiang, China, and to provide experience for the prevention and control of metabolic diseases in southern Xinjiang.  Methods  The patients with GS who visited First Division Hospital, Second Division Korla Hospital, and Third Division Hospital of Xinjiang Production and Construction Corps from March 2015 to March 2019 were enrolled as case group, and cluster sampling was used to select the individuals who underwent physical examination in Third Division 51st Regiment Hospital during the same period of time were enrolled as control group. According to inclusion and exclusion criteria, 1140 cases were enrolled in each group after 1∶ 1 matching based on age and sex. The t-test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups; a logistic regression analysis was used to investigate the influencing factors for GS. Dummy variables were included by logistic regression to evaluate multiplicative interaction between MS components, and the parameter estimate and covariance matrix of the logistic regression model and interaction calculation table were used to calculate and evaluate additive interaction between MS components.  Results  The risk of GS in MS patients was 2.33 times that in non-MS patients (odds ratio [OR]=2.33, 95% confidence interval [CI]: 1.86-2.92). In addition, the components of MS also increased the risk of GS, including blood glucose (OR=2.94, 95%CI: 2.36-3.68), blood pressure (OR=1.50, 95%CI: 1.26-1.80), blood lipids (OR=1.48, 95%CI: 1.25-1.75), and body mass index (OR=1.44, 95%CI: 1.21-1.70). After adjustment for multiple factors, the risk of GS gradually increased with the increase in the number of metabolic abnormalities, i.e., one abnormality (OR=1.55, 95%CI: 1.22-1.99), two abnormalities (OR=2.13, 95%CI: 1.66-2.72), three abnormalities (OR=3.48, 95%CI: 2.59-4.69), and four abnormalities (OR=4.65, 95%CI: 2.79-7.84). No additive or multiplicative interaction was found between MS components.  Conclusion  GS is closely associated with MS in southern Xinjiang, and the risk of GS gradually increases with the increase in MS components. No additive or multiplicative interaction is found between GS and MS components.

     

    • FullText(HTML)
  • loading
    • References(33)
  • [1]
    LAMMERT F, GURUSAMY K, KO CW, et al. Gallstones[J]. Nat Rev Dis Primers, 2016, 2: 16024. DOI: 10.1038/nrdp.2016.24.
    [2]
    ZHU Q, SUN X, JI X, et al. The association between gallstones and metabolic syndrome in urban Han Chinese: a longitudinal cohort study[J]. Sci Rep, 2016, 6: 29937. DOI: 10.1038/srep29937.
    [3]
    ECKEL RH, GRUNDY SM, ZIMMET PZ. The metabolic syndrome[J]. Lancet, 2005, 365(9468): 1415-1428. DOI: 10.1016/S0140-6736(05)66378-7.
    [4]
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel Ⅲ) final report[J]. Circulation, 2002, 106(25): 3143-3421. DOI: 10.1161/circ.106.25.3143
    [5]
    YANG JL, HUANG JJ, CHENG N, et al. Sex-specific and dose-response relationship between the incidence of gallstones and components of the metabolic syndrome in Jinchang Cohort: a prospective study[J]. Biomed Environ Sci, 2020, 33(8): 633-638. DOI: 10.3967/bes2020.084.
    [6]
    TSAI CH, WU JS, CHANG YF, et al. The number of metabolic abnormalities associated with the risk of gallstones in a non-diabetic population[J]. PLoS One, 2014, 9(3): e90310. DOI: 10.1371/journal.pone.0090310.
    [7]
    YANG LZ, PENG XY, ZHANG HW, et al. A comparative analysis of the blood lipid levels and body mass index in the female patients with simple cholelithiasis of Uyghur and Han nationality[J]. Chin J Mod Med, 2021, 31(16): 59-62. DOI: 10.3969/j.issn.1005-8982.2021.16.011.

    杨凌志, 彭心宇, 张宏伟, 等. 维吾尔族与汉族女性单纯性胆囊结石患者体重指数及血脂水平的对比分析[J]. 中国现代医学杂志, 2021, 31(16): 59-62. DOI: 10.3969/j.issn.1005-8982.2021.16.011.
    [8]
    LI WD. Epidemiological analysis of gallstone in Xinjiang[J]. Contemp Med Forum, 2014, 21: 187-188. https://www.cnki.com.cn/Article/CJFDTOTAL-QYWA201421157.htm

    李卫东. 对新疆地区胆囊结石的流行病学分析[J]. 当代医药论丛, 2014, 12(21): 187-188. https://www.cnki.com.cn/Article/CJFDTOTAL-QYWA201421157.htm
    [9]
    PANG HR, XU SZ, DING YS, et al. Epidemiological characteristics of metabolic syndrome among the Kazak, Uygur and Han people aged 60 years and above in Xinjiang[J]. J Pract Med, 2014, 30(17): 2843-2846. DOI: 10.3969/j.issn.1006-5725.2014.17.053.

    庞鸿瑞, 徐上知, 丁玉松, 等. 新疆哈萨克族、维吾尔族及汉族60岁及以上老年人群代谢综合征流行特点[J]. 实用医学杂志, 2014, 30(17): 2843-2846. DOI: 10.3969/j.issn.1006-5725.2014.17.053.
    [10]
    The Cooperation Group of the Chinese Medical Association Diabetes Branch studying on the Metabolic Syndrome. Suggestion for the metabolic syndrome by the Chinese Medical Association Diabetes Branch[J]. Clin J DIabetes, 2004, 12(3): 5-10. DOI: 10.3321/j.issn:1006-6187.2004.03.002

    中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中华糖尿病杂志, 2004, 12(3): 5-10. DOI: 10.3321/j.issn:1006-6187.2004.03.002
    [11]
    ANDERSSON T, ALFREDSSON L, KÄLLBERG H, et al. Calculating measures of biological interaction[J]. Eur J Epidemiol, 2005, 20(7): 575-579. DOI: 10.1007/s10654-005-7835-x
    [12]
    MÉNDEZ-SÁNCHEZ N, CHAVEZ-TAPIA NC, MOTOLA-KUBA D, et al. Metabolic syndrome as a risk factor for gallstone disease[J]. World J Gastroenterol, 2005, 11(11): 1653-1657. DOI: 10.3748/wjg.v11.i11.1653.
    [13]
    NERVI F, MIQUEL JF, ALVAREZ M, et al. Gallbladder disease is associated with insulin resistance in a high risk Hispanic population[J]. J Hepatol, 2006, 45(2): 299-305. DOI: 10.1016/j.jhep.2006.01.026.
    [14]
    LITTLEFIELD A, LENAHAN C. Cholelithiasis: presentation and management[J]. J Midwifery Womens Health, 2019, 64(3): 289-297. DOI: 10.1111/jmwh.12959.
    [15]
    LIOUDAKI E, GANOTAKIS ES, MIKHAILIDIS DP. Lipid lowering drugs and gallstones: a therapeutic option?[J]. Curr Pharm Des, 2011, 17(33): 3622-3631. DOI: 10.2174/138161211798220909.
    [16]
    SHEBL FM, ANDREOTTI G, MEYER TE, et al. Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China[J]. Br J Cancer, 2011, 105(9): 1424-1429. DOI: 10.1038/bjc.2011.363.
    [17]
    NAKEEB A, COMUZZIE AG, Al-Azzawi H, et al. Insulin resistance causes human gallbladder dysmotility[J]. J Gastrointest Surg, 2006, 10(7): 940-948, 948-949. DOI: 10.1016/j.gassur.2006.04.005.
    [18]
    LIU CM, HSU CT, LI CY, et al. A population-based cohort study of symptomatic gallstone disease in diabetic patients[J]. World J Gastroenterol, 2012, 18(14): 1652-1659. DOI: 10.3748/wjg.v18.i14.1652.
    [19]
    AUNE D, VATTEN LJ. Diabetes mellitus and the risk of gallbladder disease: A systematic review and meta-analysis of prospective studies[J]. J Diabetes Complications, 2016, 30(2): 368-373. DOI: 10.1016/j.jdiacomp.2015.11.012.
    [20]
    ALI AK, ADETUNJI OR. Incidence and prevalence of bile duct and gallbladder disease in patients with diabetes in the U.S. [J]. Diabetes, 2018, 67(Suppl 1): 1559-P. DOI: org/10.2337/db18-1559-P.
    [21]
    BIDDINGER SB, HAAS JT, YU BB, et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones[J]. Nat Med, 2008, 14(7): 778-782. DOI: 10.1038/nm1785.
    [22]
    de BOER SY, MASCLEE AA, LAMERS CB. Effect of hyperglycemia on gastrointestinal and gallbladder motility[J]. Scand J Gastroenterol Suppl, 1992, 194: 13-18. DOI: 10.3109/00365529209096020.
    [23]
    PORTINCASA P, MOSCHETTA A, PALASCIANO G. Cholesterol gallstone disease[J]. Lancet, 2006, 368(9531): 230-239. DOI: 10.1016/S0140-6736(06)69044-2.
    [24]
    LIEW PL, WANG W, LEE YC, et al. Gallbladder disease among obese patients in Taiwan[J]. Obes Surg, 2007, 17(3): 383-390. DOI: 10.1007/s11695-007-9068-4.
    [25]
    LIN IC, YANG YW, WU MF, et al. The association of metabolic syndrome and its factors with gallstone disease[J]. BMC Fam Pract, 2014, 15: 138. DOI: 10.1186/1471-2296-15-138.
    [26]
    CHEN LY, QIAO QH, ZHANG SC, et al. Metabolic syndrome and gallstone disease[J]. World J Gastroenterol, 2012, 18(31): 4215-4220. DOI: 10.3748/wjg.v18.i31.4215.
    [27]
    WANG J, SHEN S, WANG B, et al. Serum lipid levels are the risk factors of gallbladder stones: a population-based study in China[J]. Lipids Health Dis, 2020, 19(1): 50. DOI: 10.1186/s12944-019-1184-3.
    [28]
    KIM SS, LEE JG, KIM DW, et al. Insulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal women[J]. Korean J Intern Med, 2011, 26(3): 285-293. DOI: 10.3904/kjim.2011.26.3.285.
    [29]
    AMIGO L, ZANLUNGO S, MENDOZA H, et al. Risk factors and pathogenesis of cholesterol gallstones: state of the art[J]. Eur Rev Med Pharmacol Sci, 1999, 3(6): 241-246.
    [30]
    BAI JD, XUE RQ, BAI YL, et al. Association between metabolic syndrome and gallstones[J]. J Clin Hepatol, 2020, 36(3): 701-703. DOI: 10.3969/j.issn.1001－5256.2020.03.052.

    白济东, 薛荣泉, 白永乐, 等. 代谢综合征与胆囊结石的关系[J]. 临床肝胆病杂志, 2020, 36(3): 701-703. DOI: 10.3969/j.issn.1001－5256.2020.03.052.
    [31]
    GUO S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms[J]. J Endocrinol, 2014, 220(2): T1-T23. DOI: 10.1530/JOE-13-0327.
    [32]
    KARHAPÄÄ P, MALKKI M, LAAKSO M. Isolated low HDL cholesterol. An insulin-resistant state[J]. Diabetes, 1994, 43(3): 411-417. DOI: 10.2337/diab.43.3.411.
    [33]
    JANZON L, ASPELIN P, ERIKSSON S, et al. Ultrasonographic screening for gallstonedisease in middle-aged women. Detection rate, symptoms, and biochemical features[J]. Scand J Gastroenterol, 1985, 20(6): 706-710.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (342) PDF downloads(21) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return